A systematic review titled "Denosumab-efficacy, safety, persistence and sequential strategies-a systematic review" was published on October 2, 2026. The publication appeared in Osteoporosis International, a journal established through cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. The review addresses denosumab efficacy, safety, persistence, and sequential treatment strategies, which may include approaches involving teriparatide. This is listed as a new publication entry under the compound teriparatide. No findings, outcomes, or conclusions from the review have been provided in this report. The event data confirms only the title, journal, and publication date. Teriparatide remains an approved compound. Readers interested in background on teriparatide can consult the compound overview for additional context.
New Publication Reviews Denosumab, Sequential Teriparatide Strategies
See the full teriparatide overview
Source: https://pubmed.ncbi.nlm.nih.gov/42825930/